Evaluation of a cumulative SUV-volume histogram method for parameterizing heterogeneous intratumoural FDG uptake in non-small cell lung cancer PET studies
about
Characterization of PET/CT images using texture analysis: the past, the present… any future?Do clinical, histological or immunohistochemical primary tumour characteristics translate into different (18)F-FDG PET/CT volumetric and heterogeneity features in stage II/III breast cancer?Intratumoral Metabolic Heterogeneity for Prediction of Disease Progression After Concurrent Chemoradiotherapy in Patients with Inoperable Stage III Non-Small-Cell Lung Cancer.Recent Trends in PET Image Interpretations Using Volumetric and Texture-based Quantification Methods in Nuclear Oncology.Three-dimensional fractal analysis of 99mTc-MAA SPECT images in chronic thromboembolic pulmonary hypertension for evaluation of response to balloon pulmonary angioplasty: association with pulmonary arterial pressureCorrelation of intra-tumor 18F-FDG uptake heterogeneity indices with perfusion CT derived parameters in colorectal cancer.Quantifying metabolic heterogeneity in head and neck tumors in real time: 2-DG uptake is highest in hypoxic tumor regions.Intratumoral heterogeneity of breast cancer xenograft models: texture analysis of diffusion-weighted MR imaging.Comparison of texture features derived from static and respiratory-gated PET images in non-small cell lung cancerPretreatment (18)F-FDG uptake heterogeneity can predict survival in patients with locally advanced nasopharyngeal carcinoma--a retrospective studyPrognostic significance of metabolic tumor burden by positron emission tomography/computed tomography in patients with relapsed/refractory diffuse large B-cell lymphoma.Prognostic value of metabolic metrics extracted from baseline positron emission tomography images in non-small cell lung cancer.Textural features in pre-treatment [F18]-FDG-PET/CT are correlated with risk of local recurrence and disease-specific survival in early stage NSCLC patients receiving primary stereotactic radiation therapy.Effects of rigid and non-rigid image registration on test-retest variability of quantitative [18F]FDG PET/CT studiesReproducibility of (18)F-FDG PET uptake measurements in head and neck squamous cell carcinoma on both PET/CT and PET/MRComputerized PET/CT image analysis in the evaluation of tumour response to therapy.Response assessment using 18F-FDG PET early in the course of radiotherapy correlates with survival in advanced-stage non-small cell lung cancerA method for model-free partial volume correction in oncological PET.The value of intratumoral heterogeneity of (18)F-FDG uptake to differentiate between primary benign and malignant musculoskeletal tumours on PET/CT.A novel metric for quantification of homogeneous and heterogeneous tumors in PET for enhanced clinical outcome prediction.Applications and limitations of radiomicsDetermination of regional lymph node status using (18)F-FDG PET/CT parameters in oesophageal cancer patients: comparison of SUV, volumetric parameters and intratumoral heterogeneity.Repeatability of Radiomic Features in Non-Small-Cell Lung Cancer [(18)F]FDG-PET/CT Studies: Impact of Reconstruction and Delineation.Tumor quantification in clinical positron emission tomography.Positron emission tomography/computerized tomography for tumor response assessment-a review of clinical practices and radiomics studiesFDG uptake heterogeneity in FIGO IIb cervical carcinoma does not predict pelvic lymph node involvement.Effects of reusing baseline volumes of interest by applying (non-)rigid image registration on positron emission tomography response assessments.The human box C/D snoRNAs U3 and U8 are required for pre-rRNA processing and tumorigenesis.The impact of intratumoral metabolic heterogeneity on postoperative recurrence and survival in resectable esophageal squamous cell carcinoma.PET/CT in therapy evaluation of patients with lung cancer.The role of texture analysis in imaging as an outcome predictor and potential tool in radiotherapy treatment planning.Review of clinical practice utility of positron emission tomography with 18F-fluorodeoxyglucose in assessing tumour response to therapyNonsurgical giant cell tumour of the tendon sheath or of the diffuse type: are MRI or 18F-FDG PET/CT able to provide an accurate prediction of long-term outcome?A Novel Framework for Automated Segmentation and Labeling of Homogeneous Versus Heterogeneous Lung Tumors in [18F]FDG-PET Imaging.Radiomics strategies for risk assessment of tumour failure in head-and-neck cancer.Evaluation of the Efficacy of Standardized Uptake Value (SUV)-shape Scheme for Thyroid Volume Determination in Graves' Disease: A Comparison with Ultrasonography.[(18)F]FDG PET/CT features for the molecular characterization of primary breast tumors.Hodgkin Lymphoma: Current Status and Clinical Trial Recommendations.Quantitative radiomics studies for tissue characterization: a review of technology and methodological procedures.Mucolytic Agents Can Enhance HER2 Receptor Accessibility for [(89)Zr]Trastuzumab, Improving HER2 Imaging in a Mucin-Overexpressing Breast Cancer Xenograft Mouse Model.
P2860
Q30837034-34EA5D73-3FE3-4122-BBD6-52493843CA5EQ33576007-E640E306-FAE0-4542-8B4D-B993ABB77F8DQ33669810-D160CCBB-B3E8-4E63-A55A-6FA54B36DDA8Q33669828-9F0D36EA-8F01-4EA0-B1BD-765AF1A7665BQ33693393-E3AB79E7-43E7-4C7C-A86A-3129E7F79C9BQ33753620-6110FDF9-7CC8-42EC-820F-0D9931B1F672Q34050564-4169EF44-A63B-4789-9AE9-8673B64319B0Q34219611-82B879D0-EC5B-4372-861B-BB780820A379Q34724752-932406EC-8B72-4294-917D-962B61AA9CC4Q35030360-74478F93-057B-4015-804D-37BF6330C485Q35439403-10E81F90-6389-4BE7-9811-C568B4385AC0Q35731341-FFF6027B-9D53-4F82-8BA5-251F828199A6Q35734154-ACE6398E-8C82-45A7-A00F-2A93D44BE520Q35950812-9F542CE5-8655-4993-B212-5EA5DF7E6D96Q36295389-D03BA1E5-645C-4528-B7AE-0C5C6142CC44Q36295403-CDA0789E-D4F1-4F5E-8727-B0A1E30574D8Q36341962-FB41131C-6E6D-4285-AC98-F1031E1DD7DAQ36411892-A3E25541-914C-48B9-9E0F-42C3EEC3B058Q36550616-A20BB498-F36C-4AF8-A88A-B4501512B1C1Q36951545-37132376-6CC4-42ED-985A-0EA32AFA0092Q37052862-4A6A7E26-A7E9-41E4-A2CA-2138FA590301Q37175679-D44CFE6F-C757-4206-8083-FB488B286866Q37230607-B791B5A3-5A9A-4277-A162-C7495FBACCF8Q37342658-455B1CE5-8AB6-441F-850A-6B0F54A2A590Q37444081-1AAACCAB-7001-4E45-A32C-91214BF10AA4Q37522745-FCC78078-4DBA-424C-B17A-0BF947B1C0F0Q37525550-3F80405A-B76E-469D-B953-0901CAA1E71EQ37644889-956A58B9-DDDC-4FDE-9336-8A2CDC5516A3Q37716473-E6B1491F-2BF2-47D4-9DF3-73139DF9C51EQ38202189-546AF200-B38D-4EA6-8BAF-E291FD6065A0Q38232757-9BE421EB-1B20-4F52-AE24-255D377FB38DQ38243086-7A9D63F1-B1EE-4BCD-84B9-84E7BB11F94CQ38264850-CBDCD704-A56E-4BE6-B570-6867E684EEE5Q38405052-84C1A359-90F8-48B6-9051-050AF4237FA2Q38599041-BED47EBE-EFD4-46C4-9343-86950D3CB305Q38608880-DC683144-FABA-4B67-9991-94D9E6B9DF88Q38677216-AB317FFE-CE12-4FEC-8A3F-411AFCFF2792Q38775871-09EB81DC-B34F-4B6D-9A07-B1E0FE8227FCQ38784854-BCCF7BBF-6065-49A7-AC77-DA4785002B70Q38901000-FA9080AD-6DBB-4D98-A432-0DDCD8FE970C
P2860
Evaluation of a cumulative SUV-volume histogram method for parameterizing heterogeneous intratumoural FDG uptake in non-small cell lung cancer PET studies
description
2011 nî lūn-bûn
@nan
2011 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Evaluation of a cumulative SUV ...... l cell lung cancer PET studies
@ast
Evaluation of a cumulative SUV ...... l cell lung cancer PET studies
@en
type
label
Evaluation of a cumulative SUV ...... l cell lung cancer PET studies
@ast
Evaluation of a cumulative SUV ...... l cell lung cancer PET studies
@en
prefLabel
Evaluation of a cumulative SUV ...... l cell lung cancer PET studies
@ast
Evaluation of a cumulative SUV ...... l cell lung cancer PET studies
@en
P2093
P2860
P1476
Evaluation of a cumulative SUV ...... l cell lung cancer PET studies
@en
P2093
Egbert F Smit
Floris H P van Velden
Maqsood Yaqub
Otto S Hoekstra
Patsuree Cheebsumon
P2860
P2888
P304
P356
10.1007/S00259-011-1845-6
P577
2011-05-27T00:00:00Z